The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Aims to boost speed & precision in patient care
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The system is powered by BrainSense technology, which has received approval from USFDA
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
Subscribe To Our Newsletter & Stay Updated
